| Pharmaceutical active ingredients: |
| HydrochlorothiazideLisinopril |
| Available forms, composition and doses of Zestoretic Mite: |
| Tablets; Oral; Hydrochlorothiazide 12.5 mg; Lisinopril 10 mg |
| Zestoretic Mite medical category: |
| Human:Angiotensin-Converting Enzyme inhibitorsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09BA03 - Lisinopril and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AstraZeneca |
| Related documents and information about Zestoretic Mite: |
| Zestoretic prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tobicor Plus | Hydrochlorothiazide; Lisinopril | Teva |
| Tonotensil D | Hydrochlorothiazide; Lisinopril | Chile Laboratorios |
| Vivatec Comp | Hydrochlorothiazide; Lisinopril | Merck |
| Vivazid | Hydrochlorothiazide; Lisinopril | Merck |
| Zestoretic | Hydrochlorothiazide; Lisinopril | AstraZeneca; Cana; Four Star; Zuellig Pharma |
| Zonapril-H | Hydrochlorothiazide; Lisinopril | VHB Lifesciences |
| Lipril-H | Hydrochlorothiazide; Lisinopril Andydrous | Lupin Pharmaceuticals |
| Co-Lisinopril | Hydrochlorothiazide; Lisinopril Dihydrate | 1 A Pharma |
| Co-Lisinopril | Hydrochlorothiazide; Lisinopril Dihydrate | Sandoz |
| Corpriretic | Hydrochlorothiazide; Lisinopril Dihydrate | G. Streuli |